KERMIT E. OSSERMAN, M.D.; HENRY DOLGER, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
In the treatment of the obese diabetic, management of the obesity is secondary to insulin in the control of diabetes mellitus. Mirsky1 considers the obese diabetic as being "decompensated" with a relative or absolute insulin insufficiency. With decreased caloric intake and consequent weight reduction, the patient may be restored to "compensation" and the insufficiency of insulin can equal the reduced metabolic demand. If the diabetic patient remains obese, not only may the control of the diabetes become more and more difficult, but reduction in weight eventually may not be effective in restoring carbohydrate tolerance.2 The relative insufficiency of insulin then
OSSERMAN KE, DOLGER H. OBESITY IN DIABETES: A STUDY OF THERAPY WITH ANOREXIGENIC DRUGS1. Ann Intern Med. ;34:72–79. doi: 10.7326/0003-4819-34-1-72
Download citation file:
Published: Ann Intern Med. 1951;34(1):72-79.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Obesity.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use